Myriad Genetics recently launched myRisk Hereditary Cancer

Written by  
Myriad Genetics, Inc. recently announced that it has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test that will provide increased sensitivity by analyzing 25 genes associated with eight major cancers including breast, colorectal, ovarian, endometrial, pancreatic, prostate, gastric and melanoma cancer.

Want to read more?

Subscribe to one of our monthly plans to continue reading this article.

Login to post comments

February 2024

Brands of the Month

  • Eminence Organic Skin Care
  • Celluma by Biophotas, Inc
  • DMK Skin Revision Center

Trending Industry News

body { overflow-y: auto; } html, body { min-width: unset; }